Europe Viscosupplementation Market Size & Outlook, 2025-2033

The viscosupplementation market in Europe is expected to reach a projected revenue of US$ 1,359.1 million by 2033. A compound annual growth rate of 7.3% is expected of Europe viscosupplementation market from 2025 to 2033.
Revenue, 2024 (US$M)
$700.7
Forecast, 2033 (US$M)
$1,359.1
CAGR, 2025 - 2033
7.3%
Report Coverage
Europe

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe viscosupplementation market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe viscosupplementation market highlights

  • The Europe viscosupplementation market generated a revenue of USD 700.7 million in 2024.
  • The market is expected to grow at a CAGR of 7.3% from 2025 to 2033.
  • In terms of segment, single injection was the largest revenue generating product in 2024.
  • Single Injection is the most lucrative product segment registering the fastest growth during the forecast period.
  • Country-wise, Denmark is expected to register the highest CAGR from 2025 to 2033.


Europe data book summary

Market revenue in 2024USD 700.7 million
Market revenue in 2033USD 1,359.1 million
Growth rate7.3% (CAGR from 2025 to 2033)
Largest segmentSingle injection
Fastest growing segmentSingle Injection
Historical data covered2021 - 2023
Base year for estimation2024
Forecast period covered2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationSingle Injection, Three Injection, Five Injection
Key market players worldwideDePuy Synthes, Sanofi SA, Smith & Nephew PLC, Anika Therapeutics Inc, Zimmer Biomet Holdings Inc, Ferring, Lifecore Biomedical Inc, LG Chem, Roche Holding AG


Other key industry trends

  • In terms of revenue, Europe region accounted for 13.2% of the global viscosupplementation market in 2024.
  • Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2033.
  • Europe is the fastest growing regional market and is projected to reach USD 1,359.1 million by 2033.

Single injection was the largest segment with a revenue share of 48.15% in 2024. Horizon Databook has segmented the Europe viscosupplementation market based on single injection, three injection, five injection covering the revenue growth of each sub-segment from 2021 to 2033.


The region witnessed a slight slowdown in market growth, owing to ongoing economic turmoil and growing competition in the market. However, it is anticipated that with the introduction of single injection treatments, the market is likely to recover. It is expected that the European viscosupplement market will witness a significant shift from multiple-injection cycle products to single-injection treatment, owing to greater convenience of the latter.

Europe regulatory system is comparatively less stringent for hyaluronic acid products than the U.S. In June 2016, Anika Therapeutics, Inc. launched CINGAL in Europe. The company intended to make the product available in Germany, Poland, Italy, Czech Republic, and Hungary. The product received CE mark in March 2016.

Large number of clinical trials are being conducted to provide efficient treatment for knee osteoarthritis with the help of stem cells. The European Union´s Horizon 2020 research funding program has provided approximately USD 6.5 million to the ADIPOA-2 project and includes 18 partners from Germany, Italy, France, the Netherlands, Ireland, and the UK.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Viscosupplementation Market Companies

Name Profile # Employees HQ Website
Lifecore Biomedical Inc View profile 459 3515 Lyman Boulevard, Chaska, MN, United States, 55318 https://www.lifecore.com
Ferring View profile 5001-10000 Saint-prex, Vaud, Switzerland, Europe https://www.ferring.com
Anika Therapeutics Inc View profile 357 32 Wiggins Avenue, Bedford, MA, United States, 01730 https://www.anika.com
LG Chem View profile 10001+ Seoul, Seoul-t'ukpyolsi, South Korea, Asia https://www.lgchem.com
Smith & Nephew PLC View profile 18452 Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, United Kingdom, WD18 8YE https://www.smith-nephew.com
DePuy Synthes View profile 5001-10000 Raynham, Massachusetts, United States, North America https://depuysynthes.com
Zimmer Biomet Holdings Inc View profile 18000 345 East Main Street, Warsaw, IN, United States, 46580 https://www.zimmerbiomet.com
Roche Holding AG View profile 103605 Grenzacherstrasse 124, Basel, Switzerland, 4070 https://www.roche.com
Sanofi SA View profile 87994 46, avenue de la Grande Armée, Paris, France, 75017 https://www.sanofi.com

Europe viscosupplementation market size, by country, 2021-2033 (US$M)

Europe Viscosupplementation Market Outlook Share, 2024 & 2033 (US$M)

Europe viscosupplementation market size, by country, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online